Conservative surgery, external radiotherapy, and HDR brachytherapy in a single fraction of 7 Gy in early breast cancer: Long-term toxicity and esthetic assessment

Clinical and Translational Oncology

Volumn 14, Issue 12, 2012, Pages 953-960

  Rodríguez Pérez, Aurora ^a   López Carrizosa, Maria Concepción ^a   Samper Ots, Pilar Maria ^a   Pérez Regadera Gómez, José Fermín ^b   Zapatero Ortuño, José ^a   Sáez Garrido, Juan De Dios ^a   Martín De Miguel, Manuel Joaquín ^a  

^a HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Boost; Breast cancer; Cosmetic results; Early stage; HDR brachytherapy; Late toxicity

Indexed keywords

ADULT; ATROPHY; BRACHYTHERAPY; BREAST CANCER; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESTHETIC SURGERY; EXTERNAL BEAM RADIOTHERAPY; FIBROSIS; HUMAN; LYMPHEDEMA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PAIN; PARTIAL MASTECTOMY; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION INJURY; REVIEW; TELANGIECTASIA;

EID: 84878621690     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0881-4     Document Type: Review

References (34)

1. Olivotto IA, Rose MA, Osteen RT et al (1989) Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys 17:747-753
2. Harris JR, Levene MB, Svensson G et al (1979) Analysis of cosmetic results following primary radiation therapy for stage I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys 5:257-261
3. Beadle GF, Silver B, Botnick L et al (1984) Cosmetic outcome following primary radiation therapy for early breast cancer. Cancer 54:2911-2918
4. Rose MA, Olivotto I, Cady B et al (1989) Conservative surgery and radiation therapy for early breast cancer. Long term cosmetic results. Arch Surg 124:153-157
5. Clarke DH, Le MG, Sarrazin D et al (1985) Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave Roussy. Int J Radiat Oncol Biol Phys 11:137-145
6. Van Limbergen E, Rijnders A, Van der Schueren E et al (1989) Cosmetic evaluation of breast conserving treatment for mammary cáncer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol 16:253-267
7. Tavassoli FA, Devilee P (2003) (eds) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs, IARC Press, Lyon
8. Hoeller J, Kuhlmey A, Bajrovic A et al (2003) Cosmesis from patient's and the doctor's view. Int J Radiat Oncol Biol Phys 57(2):345-354
9. Fehlauer F, Tribius S, Holler U et al (2003) Long term radiation sequelae after breast conserving therapy in women with early-stage breast cancer: an observational study using the lent soma scoring system. Int J Radiat Oncol Biol Phys 55:651-658
10. Hosmer DW, Lemeshow S (2000) Applied logistic regression, University of Massachusetts, Amhearst, Mass, USA
11. Budrukkar AN, Sarin R, Shrivastava SK et al (2007) Cosmesis, late sequelae and local control after breast conserving therapy: influence of type of tumor bed boost and adjuvant chemotherapy. Clin Oncol (R Coll Radiol) 19(8):596-603 (Epub 2007 Aug 13)
12. Vass S, Bairati I (2005) A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique. Int J Radiat Oncol Biol Phys 62(5):1274-1282
13. Ulutin HC, Ash D, Dodwell D et al (2003) Brachytherapy boost to the tumor bed in high risk patients after limited surgery for breast cancer. Clin Oncol 15:156-159
14. Resch A, Potter R, Van Limbergen E et al (2002) Long term results (10 years) of intensive breast conserving therapy including a high dose and large volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer. Radiother Oncol 63:47-58
15. Hennequin C, Durdux C, Espié M et al (1999) High dose rate brachytherapy for early breast cancer: an ambulatory technique. Int J Radiat Oncol Biol Phys 45(1):85-90
16. Arenas M, Sabater S, Hernández V et al (2006) Cosmetic outcome of breast conservative treatment for early stage breast cancer. Clin Transl Oncol 8(5):334-338
17. Guinot JL, Tortajada I, Carrascosa M et al (2012) Ten year results of a phase II study with a single fraction of high-dose-rate brachytherapy (FAST-boost) after whole breast irradiation in invasive breast cancer. Clin Transl Oncol 14:109-115
18. Wazer DE, Kramer B, Schmid C et al (1997) Factors determining outcome in patients treated with interstitial implantation as a radiation boost for breast conservation therapy. Int J Radiat Oncol Biol Phys 39(2):381-393
19. Taylor ME, Pérez CA, Halverson KJ et al (1995) Factors influencing cosmetic results after breast conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 31(4):753-764
20. Neumanova R, Petera J, Frgala T (2007) Long term outcome with interstitial brachytherapy boost in the treatment of women with early stage breast cáncer. Neoplasma 54(5):413-423
21. Romestaing P, Lehingue Y, Carrie C et al (1997) Role of a 10 Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon. France. J Clin Oncol 15:963-968
22. Manning MA, Arthur DW, Schmidt-Ullrich RK et al (2000) Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme. Int J Radiat Oncol Biol Phys 48(5):1301-1306
23. Vrieling C, Colette L, Fourquet A et al (2000) The influence of patient, tumor and treatment factors on the cosmetic results after breast conserving therapy in the EORTC « boost vs no boost » trial. Radiother Oncol 55:219-232
24. Hammer J, Seewald DH, Track C et al (1994) Breast cancer: primary treatment with external beam radiation therapy and high dose rate iridium implantation. Radiology 193(2):573-577
25. Steeves RA, Phromratanaponge P, Wolberg WH et al (1989) Cosmetic and local control alter irradiation in women treated conservatively for breast cancer. Arch Surg 124:1369-1374
26. Sarin R, Dinshaw KA, Shrivastava SK et al (1993) Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. Int J Radiat Oncol Biol Phys 27:285-292
27. Toledano AH, Bollet MA, Fourquet A et al (2007) Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast conserving surgery? Results of the Arcosein multicenter phase III study: patients' and doctors' views. Int J Radiat Oncol Biol Phys 68(1):66-72
28. Ryoo MC, Kagan AR, Wollin M et al (1989) Prognostic factors for recurrence and cosmesis in 393 patients radiation therapy for early mammary carcinoma. Radiology 17:555-559
29. Polgar C, Fodor J, Orosz Z et al (2002) Electron and high dose rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial. Strahlenther Onkol 178:615-623
30. Dewar JA, Benhamou S, Benhamou E et al (1988) Cosmetic results following lumpectomy, axillary dissection and radiotherapy in small breast câncer. Radiother Oncol 12:273-280
31. De la Rochefordière A, Abner AL, Silver B et al (1993) Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? Int J Radiat Oncol Biol Phys 26:601-606
32. Fourquet A, Campana F, Mosseri V et al (1995) Iridium 192 versus Cobalt 60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial. Rad Onc 34:114-120
33. López Carrizosa MC, Samper Ots PM, Vallejo Ocaña MC et al (2005) Early stage breast cancer conserving therapy: high dose rate brachytherapy boost to the tumor bed. Clin Transl Oncol 7(8):344-350
34. Waser D, Di Petrillo T, Schnidt-Ulrich R et al (1992) Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early stage breast carcinoma. J Clin Oncol 10:356-363